In addition, we provide initial evidence justifying further exploration of the involvement of the histone H3 variants in epigenetic dysregulation of glioma cells and cancer malignancy, which may be extended to other histones (i.e., H2A, H2B and H4). This evidence concerns the gene H2BC21 and cancer.